G7 logo with woman looking at her smartphone

Dexcom G7 has received FDA clearance

A new era of diabetes management. Coming early 2023.

  • Stay up to date on Dexcom G7

powerful. simple.

Our smallest, most accurate,1 and easiest to use,2 the Dexcom G7 Continuous Glucose Monitoring (CGM) System has been cleared by the FDA. Read our full press release for more details.
  • View press release

say hello to the amazing new Dexcom G7

hand holding smart phone displaying g7 app
#1 in accuracy
The most accurate CGM system cleared in the US1
small and discreet
So comfortable, you’ll forget you’re wearing it†,3
fastest warmup time
2x faster warmup than any other CGM system
redesigned app
Your glucose numbers, trends, and results, all on one simple screen
Smart device sold separately.*
pregnant woman holding their stomach with dexcom product on

the only iCGM system trusted for use during pregnancy

Dexcom G7 provides real-time numbers at a glance, delivering better peace of mind to pregnant patients managing type 1, type 2, and gestational diabetes.
 

FAQs

our experts are here to help.

*Compatible smart devices sold separately. For a list of compatible devices, visit dexcom.com/compatibility 86% of testers said they forgot it was on usually or some of the time. Dexcom G7 can complete warmup within 30 minutes, whereas other CGM brands require up to an hour or longer. §Comparison of NPS scores of Dexcom, Abbott, and Medtronic, Seagrove Survey 2021 Patient Perspectives. Results obtained with a prior generation Dexcom CGM system. #Separate Follow app and internet connection required. Users should always confirm readings on the Dexcom G6 app or receiver before making treatment decisions. **Compared to a prior generation Dexcom CGM System. ††An internet connection is required for patients to send their glucose data to Dexcom Clarity via a compatible smart device: dexcom.com/compatibility. ‡‡Healthcare providers will only be able to view a patient’s glucose data if the patient elects to share it with them through Dexcom Clarity.
1 Dexcom, data on file, 2022. 2 Dexcom, data on file, 2021. 3 Dexcom, data on file, 2020. 4 dQ&A US Q1 2021 Diabetes Connections Patient Panel Report. 2021;69-72. 5 Seagrove HCP Survey Q1 2021. 2021;65. 6 Beck RW, et al. JAMA. 2017;317(4):371-378. 7 Welsh JB, et al. J Diabetes Sci Technol. Jun 13 2022:19322968221099879. 8 Managed Markets Insights & Technology, LLC. MMIT Analytics, June 2022. 9 Dexcom G7 CGM System User Guide. 2022.
BRIEF SAFETY STATEMENT: Failure to use the Dexcom G7 Continuous Glucose Monitoring System (G7) and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the G7 do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.
Privacy PolicyTerms of Use

LBL-1001419 Rev002

LBL-1002430 Rev001

©

Dexcom, Inc. All rights reserved.

US flag

US

Change Region